NPEPPS and dementia: The development of dementia from MCI to dementia can be examined closer using proteomic biomarkers such as hsp1A, puromycin-sensitive aminopeptidase, and prostaglandin F2 receptor negative regulator, as per Muraoka and colleagues [106].